The American Urological Association Symptom Index for Benign Prostatic Hyperplasia

Barry, 1990, Epidemiology and natural history of benign prostatic hyperplasia, Urol. Clin. N. Amer., 17, 495, 10.1016/S0094-0143(21)00963-0

Graves, 1989, Detailed diagnoses and procedures, National Hospital Discharge Survey: 1987, Natl. Center for Health Statistics. Vital Health Stat., 13, 295

Holtgrewe, 1990, American Urological Association survey of transurethral prostatectomy and the impact of changing Medicare reimbursement, Urol. Clin. N. Amer., 17, 587, 10.1016/S0094-0143(21)00971-X

Barry, 1990, Medical outcomes research and benign prostatic hyperplasia, Prostate, 3, 61, 10.1002/pros.2990170507

Mebust, 1989, Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3, 885 patients, J. Urol., 141, 243, 10.1016/S0022-5347(17)40731-2

Lepor, 1989, Nonoperative management of benign prostatic hyperplasia, J. Urol., 141, 1283, 10.1016/S0022-5347(17)41282-1

Madsen, 1983, A point system for selecting operative candidates, 763

Boyarsky, 1977, A new look at bladder neck obstruction by the Food and Drug Administration regulators: guidelines for investigation of benign prostatic hypertrophy, Trans. Amer. Ass. Genito-Urin. Surg., 68, 29

Fowler, 1988, Symptom status and quality of life following prostatectomy, J.A.M.A., 259, 3018, 10.1001/jama.1988.03720200040030

Kleinbaum, 1982, 152

Agresti, 1984, 159

Cronbach, 1951, Coefficient alpha and the internal structure of tests, Psychometrika, 16, 297, 10.1007/BF02310555

Hanley, 1982, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, 143, 29, 10.1148/radiology.143.1.7063747

Hanley, 1988, The robustness of the “binomial” assumptions used in fitting ROC curves, Med. Decis. Making, 8, 197, 10.1177/0272989X8800800308

Kirshner, 1985, A methodological framework for assessing health indices, J. Chron. Dis., 38, 27, 10.1016/0021-9681(85)90005-0

Bruskewitz, 1982, Value of postvoid residual urine determination in evaluation of prostatism, Urology, 20, 602, 10.1016/0090-4295(82)90308-9

Golomb, 1992, Variability and circadian changes in home uroflowmetry in patients with benign prostatic hyperplasia compared to normal controls, J. Urol., 147, 1044, 10.1016/S0022-5347(17)37462-1